KCI Biotech (SUZHOU) Inc. (KCI) and Jiangsu KMQ biotech Inc. (KMQ) which is a wholly-owned subsidiary of KCI are preclinical Contract Research Organization (CRO) providing specialty preclinical pharmacology services in cardiovascular diseases, immune diseases, inflammatory diseases, metabolic diseases, urinary diseases, neuron diseases and oncology by using small (mice, rats, etc.) and large (non human primates, pigs, dogs, rabbits, guinea pig etc.) animal disease models. The core competency of KCI&KMQ stems from our pioneering work and expertise in developing and running specialized animal disease models to test drug candidates and medical devices for their pharmacological effects and biocompatible. We also conduct adjacency studies in PK/PD, preliminary toxicology, medical image, translational medicine and pathology.
凯斯艾生物科技（苏州）有限公司（KCI）及其旗下的全资子公司江苏珂玛麒生物科技有限公司（KMQ）是一家为医药研发领域提供临床前药效及成药性评价技术服务的CRO公司。致力于建立小动物（小鼠，大鼠）、大动物（非人灵长类动物非人灵长类动物，猪，犬，兔，豚鼠等）综合性临床前药效及成药性评价平台。在心血管疾病、免疫性疾病、炎症性疾病、代谢性疾病、泌尿系统疾病，神经疾病和肿瘤疾病等领域提供专业的临床前药理药效学评价服务。KCI与KMQ的核心竞争力来源于我们的创新和专业开发以及运行专项的疾病动物模型，以测试候选药物和医疗器械的药理作用和生物相关性。我们还进行PK/PD，早期非GLP毒理学，医学影像学，转化医学和病理学的研究服务。
KCI locates in Suzhou industry park. We have 7200sq.ft. of SPF animal facility for about 7000 mice and 5000 rats studies at same time; 5400sq.ft. of experimental laboratories for pathology, cell biology, molecular biology, formulation and other functional laboratories. KMQ, our large animal facility locates in Haimen (Linjiang), is about 50,000sq.ft. for guinea pigs, rabbits, dogs, pigs and NHP studies at same time; 22000sq.ft. of experimental laboratories for image facility including MRI, CT, X-ray, B-Ultrasound, operation rooms, cell biology, molecular biology, formulation and other functional laboratories.
凯斯艾位于苏州工业园区金鸡湖畔纳米城内，办公、实验面积1800㎡，其中大、小鼠SPF级屏障系统800㎡，功能性实验室600㎡，可同时开展7000只小鼠、5000只大鼠药理、药效学实验。同时旗下子公司珂玛麒拥有7600㎡的大动物实验基地（坐落在江苏海门临江生物医药园）。该实验基地拥有5000㎡的动物房，可同时开展豚鼠，兔，犬，猪以及实验非人灵长类动物的不同体内药效学实验，2000㎡的功能实验室设有MRI，CT，X-线，B-超实验室，动物手术室和其它功能实验室。
业务范围：
基础生物医学研究 动物疾病模型应用
病理学服务 转化